Skip to main content
. 2013 Aug 27;122(15):2630–2640. doi: 10.1182/blood-2012-12-473702

B. Multivariate survival analysis

OS PFS
Hazard ratio 95% CI P value Hazard ratio 95% CI P value
Overall cohort
 IPI >2 3.04 1.96-3.96 <.0001 2.59 1.8-3.62 <.0001
 B-symptoms 1.43 1.00-2.04 .048 1.49 1.06-2.10 .024
TP53 mutation 1.59 1.06-2.26 .013 1.52 1.03-2.17 .023
MUT-p53 subcohort
 IPI >2 2.03 1.05-3.93 .035 1.95 1.02-3.74 .042
 p53 >10% 2.70 1.04-7.04 .042 2.87 1.10-7.45 .031
 MDM2 >10% 2.24 1.17-4.27 .015 1.96 1.03-3.70 .041

LDH, lactate dehydrogenase; CR, complete remission; PR, partial response; SD, stable disease; PD, progressive disease.

For therapy response, we calculated P values as CR vs other responses. Some clinical features of certain cases were not available.